177 related articles for article (PubMed ID: 31492675)
41. The polycomb group protein Suz12 is required for embryonic stem cell differentiation.
Pasini D; Bracken AP; Hansen JB; Capillo M; Helin K
Mol Cell Biol; 2007 May; 27(10):3769-79. PubMed ID: 17339329
[TBL] [Abstract][Full Text] [Related]
42. HiJAKing T-ALL.
Asnafi V
Blood; 2014 Nov; 124(20):3038-40. PubMed ID: 25395141
[TBL] [Abstract][Full Text] [Related]
43. The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia.
Durinck K; Wallaert A; Van de Walle I; Van Loocke W; Volders PJ; Vanhauwaert S; Geerdens E; Benoit Y; Van Roy N; Poppe B; Soulier J; Cools J; Mestdagh P; Vandesompele J; Rondou P; Van Vlierberghe P; Taghon T; Speleman F
Haematologica; 2014 Dec; 99(12):1808-16. PubMed ID: 25344525
[TBL] [Abstract][Full Text] [Related]
44. Hedgehog pathway mutations drive oncogenic transformation in high-risk T-cell acute lymphoblastic leukemia.
Burns MA; Liao ZW; Yamagata N; Pouliot GP; Stevenson KE; Neuberg DS; Thorner AR; Ducar M; Silverman EA; Hunger SP; Loh ML; Winter SS; Dunsmore KP; Wood B; Devidas M; Harris MH; Silverman LB; Sallan SE; Gutierrez A
Leukemia; 2018 Oct; 32(10):2126-2137. PubMed ID: 29654263
[TBL] [Abstract][Full Text] [Related]
45. EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis.
Cheng AS; Lau SS; Chen Y; Kondo Y; Li MS; Feng H; Ching AK; Cheung KF; Wong HK; Tong JH; Jin H; Choy KW; Yu J; To KF; Wong N; Huang TH; Sung JJ
Cancer Res; 2011 Jun; 71(11):4028-39. PubMed ID: 21512140
[TBL] [Abstract][Full Text] [Related]
46. Absence of gain-of-function JAK1 and JAK3 mutations in adult T cell leukemia/lymphoma.
Kameda T; Shide K; Shimoda HK; Hidaka T; Kubuki Y; Katayose K; Taniguchi Y; Sekine M; Kamiunntenn A; Maeda K; Nagata K; Matsunaga T; Shimoda K
Int J Hematol; 2010 Sep; 92(2):320-5. PubMed ID: 20697856
[TBL] [Abstract][Full Text] [Related]
47. RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications.
Gianfelici V; Chiaretti S; Demeyer S; Di Giacomo F; Messina M; La Starza R; Peragine N; Paoloni F; Geerdens E; Pierini V; Elia L; Mancini M; De Propris MS; Apicella V; Gaidano G; Testi AM; Vitale A; Vignetti M; Mecucci C; Guarini A; Cools J; Foà R
Haematologica; 2016 Aug; 101(8):941-50. PubMed ID: 27151993
[TBL] [Abstract][Full Text] [Related]
48. Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27.
Kirmizis A; Bartley SM; Kuzmichev A; Margueron R; Reinberg D; Green R; Farnham PJ
Genes Dev; 2004 Jul; 18(13):1592-605. PubMed ID: 15231737
[TBL] [Abstract][Full Text] [Related]
49. Discovery of selective activators of PRC2 mutant EED-I363M.
Suh JL; Barnash KD; Abramyan TM; Li F; The J; Engelberg IA; Vedadi M; Brown PJ; Kireev DB; Arrowsmith CH; James LI; Frye SV
Sci Rep; 2019 Apr; 9(1):6524. PubMed ID: 31024026
[TBL] [Abstract][Full Text] [Related]
50. Snail2/Slug cooperates with Polycomb repressive complex 2 (PRC2) to regulate neural crest development.
Tien CL; Jones A; Wang H; Gerigk M; Nozell S; Chang C
Development; 2015 Feb; 142(4):722-31. PubMed ID: 25617436
[TBL] [Abstract][Full Text] [Related]
51. SUZ12 promotes gastric cancer cell proliferation and metastasis by regulating KLF2 and E-cadherin.
Xia R; Jin FY; Lu K; Wan L; Xie M; Xu TP; De W; Wang ZX
Tumour Biol; 2015 Jul; 36(7):5341-51. PubMed ID: 25672609
[TBL] [Abstract][Full Text] [Related]
52. MEK and PI3K-AKT inhibitors synergistically block activated IL7 receptor signaling in T-cell acute lymphoblastic leukemia.
Canté-Barrett K; Spijkers-Hagelstein JA; Buijs-Gladdines JG; Uitdehaag JC; Smits WK; van der Zwet J; Buijsman RC; Zaman GJ; Pieters R; Meijerink JP
Leukemia; 2016 Sep; 30(9):1832-43. PubMed ID: 27174491
[TBL] [Abstract][Full Text] [Related]
53. Restoration of IGF2 imprinting by polycomb repressive complex 2 docking factor SUZ12 in colon cancer cells.
Wang H; Ge S; Qian G; Li W; Cui J; Wang G; Hoffman AR; Hu JF
Exp Cell Res; 2015 Nov; 338(2):214-21. PubMed ID: 26407907
[TBL] [Abstract][Full Text] [Related]
54. Novel SUZ12 mutations in Weaver-like syndrome.
Imagawa E; Albuquerque EVA; Isidor B; Mitsuhashi S; Mizuguchi T; Miyatake S; Takata A; Miyake N; Boguszewski MCS; Boguszewski CL; Lerario AM; Funari MA; Jorge AAL; Matsumoto N
Clin Genet; 2018 Nov; 94(5):461-466. PubMed ID: 30019515
[TBL] [Abstract][Full Text] [Related]
55. Epigenetic regulation of cell adhesion and communication by enhancer of zeste homolog 2 in human endothelial cells.
Dreger H; Ludwig A; Weller A; Stangl V; Baumann G; Meiners S; Stangl K
Hypertension; 2012 Nov; 60(5):1176-83. PubMed ID: 22966008
[TBL] [Abstract][Full Text] [Related]
56. Impaired IL-7 signaling may explain a case of atypical JAK3-SCID.
Li J; Nara H; Rahman M; Juliana FM; Araki A; Asao H
Cytokine; 2010 Feb; 49(2):221-8. PubMed ID: 19889552
[TBL] [Abstract][Full Text] [Related]
57. A transgenic mouse model demonstrating the oncogenic role of mutations in the polycomb-group gene EZH2 in lymphomagenesis.
Berg T; Thoene S; Yap D; Wee T; Schoeler N; Rosten P; Lim E; Bilenky M; Mungall AJ; Oellerich T; Lee S; Lai CK; Umlandt P; Salmi A; Chang H; Yue L; Lai D; Cheng SW; Morin RD; Hirst M; Serve H; Marra MA; Morin GB; Gascoyne RD; Aparicio SA; Humphries RK
Blood; 2014 Jun; 123(25):3914-24. PubMed ID: 24802772
[TBL] [Abstract][Full Text] [Related]
58. Gene expression profiling by mRNA sequencing reveals dysregulation of core genes in Rictor deficient T-ALL mouse model.
Hua C; Chen X; Yuan W; Li Y; Yu J; Li H; Ming L
Leuk Res; 2019 Dec; 87():106229. PubMed ID: 31698306
[TBL] [Abstract][Full Text] [Related]
59. SUZ12 is a novel putative oncogene promoting tumorigenesis in head and neck squamous cell carcinoma.
Wu Y; Hu H; Zhang W; Li Z; Diao P; Wang D; Zhang W; Wang Y; Yang J; Cheng J
J Cell Mol Med; 2018 Jul; 22(7):3582-3594. PubMed ID: 29667751
[TBL] [Abstract][Full Text] [Related]
60. Description of a novel Janus kinase 3 P132A mutation in acute megakaryoblastic leukemia and demonstration of previously reported Janus kinase 3 mutations in normal subjects.
Riera L; Lasorsa E; Bonello L; Sismondi F; Tondat F; Di Bello C; Di Celle PF; Chiarle R; Godio L; Pich A; Facchetti F; Ponzoni M; Marmont F; Zanon C; Bardelli A; Inghirami G
Leuk Lymphoma; 2011 Sep; 52(9):1742-50. PubMed ID: 21599579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
